Neuropsychological Predictors of Functional Decline in Elders with Cancer

患有癌症的老年人功能下降的神经心理学预测因素

基本信息

项目摘要

DESCRIPTION (provided by applicant): Patients with cancer who are treated with surgery and adjunctive chemotherapy often have improved survival, yet they remain at risk for disabling functional decline. Cancer, like other chronic diseases affecting the aged, is associated with neuropsychological and physiological changes that likely contribute to this decline. However, this hypothesis has not been tested with longitudinal observation. Moreover, executive function, which is strongly associated with functional impairment in multivariable models, is rarely assessed in populations with cancer. No longitudinal studies have utilized neuroimaging to extend our understanding of the critical brain regions associated with functional decline. Longitudinal studies incorporating multidimensional neuropsychological assessment, neuroimaging, and serum biomarkers are needed to understand how cognition, cerebral metabolism, and physiological changes interact to precipitate functional decline in cancer survivors. The purpose of this application is to describe the one-year postsurgical change in lADL functional status and neuropsychological performance observed in non-demented elders with colon cancer referred for adjuvant chemotherapy compared to a cancer-free elder control group. We will identify the neuropsychological domains associated with functional decline in elders with colon cancer during the one-year postsurgical period. We will determine the association between post chemotherapy cerebral glucose metabolism as measured with resting fluorodeoxyglucose positron emission tomography (FDG-PET) and functional status in nondepressed colon cancer survivors. Finally, we will explore the relationship between serum biomarkers for physiological changes associated with cancer (interleukin 1, interleukin 6, hemoglobin, and albumin) and functional and cognitive decline. RELEVANCE: This study will be the first to describe longitudinal change in functional status, neuropsychological performance, and serum biomarkers for frailty across multiple methods of assessment in elder cancer survivors. It will also be the first to establish FDG-PET neuroimaging as a biomarker for functional status in elder cancer survivors. This project will inform future intervention studies that target the neuropsychological impairments and physiological changes mediating functional decline in colon cancer survivors.
描述(由申请人提供):接受手术和辅助化学疗法治疗的癌症患者的生存率通常提高,但仍处于禁用功能下降的风险。癌症与其他影响老年人的慢性疾病一样,与可能导致这种下降的神经心理学和生理变化有关。但是,该假设尚未通过纵向观察进行检验。此外,在多变量模型中与功能障碍密切相关的执行功能很少在癌症种群中评估。没有纵向研究利用神经影像来扩展我们对与功能下降相关的关键大脑区域的理解。纵向研究纳入了多维神经心理学评估,神经影像学和血清生物标志物,以了解认知,脑代谢和生理变化如何相互作用,以使癌症幸存者的功能下降相互作用。该应用的目的是描述与无癌症的老年对照组相比,在非痴呆的结肠癌中观察到的LADL功能状况和神经心理学表现的一年术后变化。我们将在一年的术后期间确定与长老患有结肠癌的功能下降相关的神经心理学领域。我们将确定化学疗法后脑葡萄糖代谢之间的关联,如静息氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)和非抑郁的结肠癌幸存者中的功能状态。最后,我们将探索与癌症(白介素1,白介素6,血红蛋白和白蛋白)与功能和认知能力下降有关的生理变化的血清生物标志物之间的关系。 相关性:这项研究将是第一个描述功能状况的纵向变化,神经心理学表现和血清生物标志物的纵向变化,以跨多种评估方法中的多种评估方法。这也将是第一个建立FDG-PET神经影像学作为在老年癌症幸存者中功能状态的生物标志物。该项目将为未来的干预研究提供信息,该研究针对神经心理学障碍和生理变化,介导结肠癌幸存者的功能下降。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASON Ellsworth SCHILLERSTROM其他文献

JASON Ellsworth SCHILLERSTROM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASON Ellsworth SCHILLERSTROM', 18)}}的其他基金

Neuropsychological Predictors of Functional Decline in Elders with Cancer
患有癌症的老年人功能下降的神经心理学预测因素
  • 批准号:
    7739653
  • 财政年份:
    2009
  • 资助金额:
    $ 15.83万
  • 项目类别:
Neuropsychological Predictors of Functional Decline in Elders with Cancer
患有癌症的老年人功能下降的神经心理学预测因素
  • 批准号:
    8131637
  • 财政年份:
    2009
  • 资助金额:
    $ 15.83万
  • 项目类别:

相似国自然基金

影响食管癌新辅助放化疗疗效的分子与影像标志物挖掘及其相关性研究
  • 批准号:
    82272941
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
影响食管癌新辅助放化疗疗效的分子与影像标志物挖掘及其相关性研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
新辅助放化疗驱动的食管鳞癌克隆进化及基因突变对食管鳞癌放化疗敏感性影响的研究
  • 批准号:
    81871975
  • 批准年份:
    2018
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目
NONO对前列腺癌脂质代谢影响及指导他汀类药物对前列腺癌的个体化治疗的研究
  • 批准号:
    81601524
  • 批准年份:
    2016
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目
新辅助放化疗对直肠癌区域淋巴结中CD169阳性T细胞的影响和调控机制
  • 批准号:
    81502459
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Intrinsic Efficacy as a Determinant of Opioid Effectiveness in Treatment of Pain-Depressed Behavior
内在功效是阿片类药物治疗疼痛抑郁行为有效性的决定因素
  • 批准号:
    10389903
  • 财政年份:
    2022
  • 资助金额:
    $ 15.83万
  • 项目类别:
Dietary fats, mitochondrial function and muscle health in cancer patients
癌症患者的膳食脂肪、线粒体功能和肌肉健康
  • 批准号:
    9456294
  • 财政年份:
    2018
  • 资助金额:
    $ 15.83万
  • 项目类别:
Systematic Light Exposure to treat Cancer-Related Fatigue in Breast Cancer Patients
系统性光照治疗乳腺癌患者与癌症相关的疲劳
  • 批准号:
    9310766
  • 财政年份:
    2017
  • 资助金额:
    $ 15.83万
  • 项目类别:
Systematic Light Exposure to treat Cancer-Related Fatigue in Breast Cancer Patients
系统性光照治疗乳腺癌患者与癌症相关的疲劳
  • 批准号:
    9927596
  • 财政年份:
    2017
  • 资助金额:
    $ 15.83万
  • 项目类别:
Systematic Light Exposure to treat Cancer-Related Fatigue in Breast Cancer Patients
系统性光照治疗乳腺癌患者与癌症相关的疲劳
  • 批准号:
    10231010
  • 财政年份:
    2017
  • 资助金额:
    $ 15.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了